Eventide Asset Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.6M | Sell |
|
|||||
|
2025
Q1 | $68.2M | Buy |
|
|||||
|
2024
Q4 | $94.8M | Buy |
|
|||||
|
2024
Q3 | $113M | Buy |
|
|||||
|
2024
Q2 | $123M | Buy |
|
|||||
|
2024
Q1 | $131M | Sell |
|
|||||
|
2023
Q4 | $144M | Buy |
|
|||||
|
2023
Q3 | $44M | Buy |
|
|||||
|
2023
Q2 | $46.7M | Hold |
|
|||||
|
2023
Q1 | $49.6M | Sell |
|
|||||
|
2022
Q4 | $65.2M | Sell |
|
|||||
|
2022
Q3 | $50.4M | Buy |
|
|||||
|
2022
Q2 | $39M | Hold |
|
|||||
|
2022
Q1 | $49.2M | Buy |
|
|||||
|
2021
Q4 | $47.9M | Buy |
|
|||||
|
2021
Q3 | $60.9M | Sell |
|
|||||
|
2021
Q2 | $70.5M | Buy |
|
|||||
|
2021
Q1 | $42.5M | Buy |
|
|||||
|
2020
Q4 | $32.2M | Buy |
|
|||||
|
2020
Q3 | $7.51M | Buy |
|
|||||
|
2020
Q2 | $6.02M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $6.59M | Buy |
|
|||||
|
2015
Q3 | $2.41M | Sell |
|
|||||
|
2015
Q2 | $7.28M | Hold |
|
|||||
|
2015
Q1 | $8.05M | Hold |
|
|||||
|
2014
Q4 | $5.27M | Hold |
|
|||||
|
2014
Q3 | $3.74M | Hold |
|
|||||
|
2014
Q2 | $4.71M | Hold |
|
|||||
|
2014
Q1 | $5.1M | Buy |
|
|||||
|
2013
Q4 | $6.22M | Buy |
|